Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 163

Similar articles for PubMed (Select 22761415)

2.

Immunohistochemical characterization of CD33 expression on microglia in Nasu-Hakola disease brains.

Satoh JI, Kino Y, Motohashi N, Ishida T, Yagishita S, Jinnai K, Arai N, Nakamagoe K, Tamaoka A, Saito Y, Arima K.

Neuropathology. 2015 Jun 18. doi: 10.1111/neup.12222. [Epub ahead of print]

PMID:
26087043
3.

Regulation of human mesenchymal stem cell differentiation by TREM-2.

Zhang W, Huang S, Huang X, Li J, Ye P, Xu J, Zheng P, Shen H, Huang J.

Hum Immunol. 2015 Jun 12. pii: S0198-8859(15)00171-8. doi: 10.1016/j.humimm.2015.06.005. [Epub ahead of print]

PMID:
26079507
4.

DAP12 Stabilizes the C-terminal Fragment of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) and Protects against LPS-induced Pro-inflammatory Response.

Zhong L, Chen XF, Zhang ZL, Wang Z, Shi XZ, Xu K, Zhang YW, Xu H, Bu G.

J Biol Chem. 2015 Jun 19;290(25):15866-77. doi: 10.1074/jbc.M115.645986. Epub 2015 May 8.

PMID:
25957402
5.

Chronic inflammation and cancer: emerging roles of triggering receptors expressed on myeloid cells.

Nguyen AH, Berim IG, Agrawal DK.

Expert Rev Clin Immunol. 2015 Jul;11(7):849-57. doi: 10.1586/1744666X.2015.1043893. Epub 2015 May 8.

PMID:
25954917
6.

The ITIM-containing receptor LAIR1 is essential for acute myeloid leukaemia development.

Kang X, Lu Z, Cui C, Deng M, Fan Y, Dong B, Han X, Xie F, Tyner JW, Coligan JE, Collins RH, Xiao X, You MJ, Zhang CC.

Nat Cell Biol. 2015 May;17(5):665-77. doi: 10.1038/ncb3158. Epub 2015 Apr 27.

PMID:
25915125
7.

Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke.

Kawabori M, Kacimi R, Kauppinen T, Calosing C, Kim JY, Hsieh CL, Nakamura MC, Yenari MA.

J Neurosci. 2015 Feb 25;35(8):3384-96. doi: 10.1523/JNEUROSCI.2620-14.2015.

PMID:
25716838
8.
9.

5-Azacytidine-induced protein 2 (AZI2) regulates bone mass by fine-tuning osteoclast survival.

Maruyama K, Fukasaka M, Uematsu S, Takeuchi O, Kondo T, Saitoh T, Martino MM, Akira S.

J Biol Chem. 2015 Apr 10;290(15):9377-86. doi: 10.1074/jbc.M114.631374. Epub 2015 Feb 17.

PMID:
25691576
10.

Cutting Edge: identification of neutrophil PGLYRP1 as a ligand for TREM-1.

Read CB, Kuijper JL, Hjorth SA, Heipel MD, Tang X, Fleetwood AJ, Dantzler JL, Grell SN, Kastrup J, Wang C, Brandt CS, Hansen AJ, Wagtmann NR, Xu W, Stennicke VW.

J Immunol. 2015 Feb 15;194(4):1417-21. doi: 10.4049/jimmunol.1402303. Epub 2015 Jan 16.

11.

Triggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity?

Roe K, Gibot S, Verma S.

Front Microbiol. 2014 Nov 26;5:627. doi: 10.3389/fmicb.2014.00627. eCollection 2014. Review.

12.

Triggering receptor expressed on myeloid cells-2 fine-tunes inflammatory responses in murine Gram-negative sepsis.

Gawish R, Martins R, Böhm B, Wimberger T, Sharif O, Lakovits K, Schmidt M, Knapp S.

FASEB J. 2015 Apr;29(4):1247-57. doi: 10.1096/fj.14-260067. Epub 2014 Dec 4.

PMID:
25477281
13.

Crosstalk among IL-23 and DNAX activating protein of 12 kDa-dependent pathways promotes osteoclastogenesis.

Shin HS, Sarin R, Dixit N, Wu J, Gershwin E, Bowman EP, Adamopoulos IE.

J Immunol. 2015 Jan 1;194(1):316-24. doi: 10.4049/jimmunol.1401013. Epub 2014 Dec 1.

PMID:
25452564
14.

Triggering receptor expressed on myeloid cells receptor family modulators: a patent review.

Pelham CJ, Pandya AN, Agrawal DK.

Expert Opin Ther Pat. 2014 Dec;24(12):1383-95. doi: 10.1517/13543776.2014.977865. Epub 2014 Nov 1.

PMID:
25363248
15.

The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis.

Genua M, Rutella S, Correale C, Danese S.

J Transl Med. 2014 Oct 28;12(1):293. doi: 10.1186/s12967-014-0293-z.

16.

Self-control of platelets: a new ITIM story.

Du X.

Blood. 2014 Oct 9;124(15):2322-3. doi: 10.1182/blood-2014-08-593830.

PMID:
25301334
17.

Role of TREM-1 in response to Aspergillus fumigatus infection in corneal epithelial cells.

Hu LT, Du ZD, Zhao GQ, Jiang N, Lin J, Wang Q, Xu Q, Cong L, Qiu S.

Int Immunopharmacol. 2014 Nov;23(1):288-93. doi: 10.1016/j.intimp.2014.09.011. Epub 2014 Sep 19.

PMID:
25242387
18.

The triggering receptor expressed on myeloid cells 2 inhibits complement component 1q effector mechanisms and exerts detrimental effects during pneumococcal pneumonia.

Sharif O, Gawish R, Warszawska JM, Martins R, Lakovits K, Hladik A, Doninger B, Brunner J, Korosec A, Schwarzenbacher RE, Berg T, Kralovics R, Colinge J, Mesteri I, Gilfillan S, Salmaggi A, Verschoor A, Colonna M, Knapp S.

PLoS Pathog. 2014 Jun 12;10(6):e1004167. doi: 10.1371/journal.ppat.1004167. eCollection 2014 Jun.

19.

Expression and regulation of triggering receptor expressed on myeloid cells 1 in periodontal diseases.

Willi M, Belibasakis GN, Bostanci N.

Clin Exp Immunol. 2014 Oct;178(1):190-200. doi: 10.1111/cei.12397.

PMID:
24924298
20.

TREM-1 is induced in tumor associated macrophages by cyclo-oxygenase pathway in human non-small cell lung cancer.

Yuan Z, Mehta HJ, Mohammed K, Nasreen N, Roman R, Brantly M, Sadikot RT.

PLoS One. 2014 May 19;9(5):e94241. doi: 10.1371/journal.pone.0094241. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk